ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,189
Screening encounters
3,668
Diagnostic referrals
700
Outstanding pathways
268

Screening pathway

  1. Screening3,668Encounters
  2. Positive finding1,263Documented findings
  3. Referral700Diagnostic referrals
  4. Follow-up812Diagnostic visits
  5. Outcome432Resolved pathways

Stage totals use different units. Pending pathways: 268. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2026-07-25, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3189 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0449 · Expanded synthetic participant 0449Site E — Resource-Constrained Navigation Programme
EXP-0450 · Expanded synthetic participant 0450Site A — Urban Referral Hub
EXP-0453 · Expanded synthetic participant 0453Site B — Peri-Urban Access Programme
EXP-0454 · Expanded synthetic participant 0454Site D — Community Engagement Programme
EXP-0455 · Expanded synthetic participant 0455Site A — Urban Referral Hub
EXP-0456 · Expanded synthetic participant 0456Site A — Urban Referral Hub
EXP-0457 · Expanded synthetic participant 0457Site D — Community Engagement Programme
EXP-0458 · Expanded synthetic participant 0458Site D — Community Engagement Programme
EXP-0460 · Expanded synthetic participant 0460Site D — Community Engagement Programme
EXP-0461 · Expanded synthetic participant 0461Site A — Urban Referral Hub
EXP-0462 · Expanded synthetic participant 0462Site D — Community Engagement Programme
EXP-0463 · Expanded synthetic participant 0463Site C — Rural Outreach Programme
EXP-0464 · Expanded synthetic participant 0464Site D — Community Engagement Programme
EXP-0465 · Expanded synthetic participant 0465Site C — Rural Outreach Programme
EXP-0466 · Expanded synthetic participant 0466Site A — Urban Referral Hub
EXP-0468 · Expanded synthetic participant 0468Site C — Rural Outreach Programme
EXP-0469 · Expanded synthetic participant 0469Site D — Community Engagement Programme
EXP-0470 · Expanded synthetic participant 0470Site C — Rural Outreach Programme
EXP-0472 · Expanded synthetic participant 0472Site A — Urban Referral Hub
EXP-0474 · Expanded synthetic participant 0474Site E — Resource-Constrained Navigation Programme
EXP-0478 · Expanded synthetic participant 0478Site D — Community Engagement Programme
EXP-0481 · Expanded synthetic participant 0481Site C — Rural Outreach Programme
EXP-0484 · Expanded synthetic participant 0484Site A — Urban Referral Hub
EXP-0485 · Expanded synthetic participant 0485Site A — Urban Referral Hub
EXP-0487 · Expanded synthetic participant 0487Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1468
HPV DNA
1674
Cytology
526

Navigation activity

Barrier documented
603
Contact attempt
1029
Navigation intervention
253
Diagnostic booking
869
Diagnostic visit
812

Documented barriers

Contact difficulty
198
Transport difficulty
189
Appointment coordination
216

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.